Florida Combined Otolaryngology Meeting 2024 – Skin Cancer: Immunotherapy

This panel will provide an in-depth discussion on the integration of immunotherapy into the management of cutaneous squamous cell carcinoma (cSCC) of the head and neck. Experts will cover the latest staging and risk stratification systems to guide treatment planning, review the effectiveness of anti-PD-1 therapy based on recent literature, and explore patient selection criteria for up-front (neoadjuvant) immunotherapy. Attendees will gain valuable insights into optimizing treatment strategies for cSCC using immunotherapy approaches. Attendees will be able to: 1. Discuss staging and risk stratification systems for cutaneous squamous cell carcinoma of the head & neck 2. Describe recent literature underlying the effectiveness of anti-PD-1 therapy for cutaneous squamous cell carcinoma 3. Discuss which patients are best treated with up-front (neoadjuvant) immunotherapy